Better show, negligible impairment perk up Dr. Reddy’s Q4 net
Dr. Reddy’s Laboratories reported consolidated net profit for the fourth quarter ended March jumped almost tenfold to ₹960.1 crore on the back of a better show in its mainstay global generics business and impairment charges being a fraction…